“Rare Schizophrenia Risk Variant Burden Is Conserved in Diverse Human Populations”, 2022-01-03 (; similar):
Schizophrenia is a chronic mental illness that is among the most debilitating conditions encountered in medical practice. A recent landmark schizophrenia study of the protein-coding regions of the genome identified a causal role for 10 genes and a concentration of rare variant signals in evolutionarily constrained genes. This study—and most other large-scale human genetic studies—was mainly composed of individuals of European ancestry, and the generalizability of the findings in non-European populations is unclear.
To address this gap in knowledge, we designed a custom sequencing panel based on current knowledge of the genetic architecture of schizophrenia and applied it to a new cohort of 22,135 individuals of diverse ancestries. Replicating earlier work, cases carried a higher burden of rare protein-truncating variants among constrained genes (OR = 1.48, p-value = 5.4 × 10−6).
In meta-analyses with existing schizophrenia datasets totaling up to 35,828 cases and 107,877 controls, this excess burden was largely consistent across 5 continental populations. Two genes (SRRM2 and AKAP11) were newly implicated as schizophrenia risk genes, and one gene (PCLO) was identified as a shared risk gene for schizophrenia and autism.
Overall, our results lend robust support to the rare allelic spectrum of the genetic architecture of schizophrenia being conserved across diverse human populations.